Listed

Dexcom Inc

DXCMNasdaqCIK 1093557HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.31bn, Q2 FY2026
Operating income$318.3m, Q2 FY2026
Net income$249.1m, Q2 FY2026
Dexcom Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m975Revenue, Q3 FY2023, three months to 2023-09-30$975.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure1,035Revenue, Q4 FY2023, three months to 2023-12-31$1.03bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure921Revenue, Q1 FY2024, three months to 2024-03-31$921.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure1,004Revenue, Q2 FY2024, three months to 2024-06-30$1.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure994Revenue, Q3 FY2024, three months to 2024-09-30$994.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure1,114Revenue, Q4 FY2024, three months to 2024-12-31$1.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure1,036Revenue, Q1 FY2025, three months to 2025-03-31$1.04bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure1,157Revenue, Q2 FY2025, three months to 2025-06-30$1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure1,209Revenue, Q3 FY2025, three months to 2025-09-30$1.21bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure1,260Revenue, Q4 FY2025, three months to 2025-12-31$1.26bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure1,192Revenue, Q1 FY2026, three months to 2026-03-31$1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure1,308Revenue, Q2 FY2026, three months to 2026-06-30$1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Cost of revenue$m352Cost of revenue, Q3 FY2023, three months to 2023-09-30$351.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure378Cost of revenue, Q4 FY2023, three months to 2023-12-31$377.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure359Cost of revenue, Q1 FY2024, three months to 2024-03-31$359.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure378Cost of revenue, Q2 FY2024, three months to 2024-06-30$377.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure400Cost of revenue, Q3 FY2024, three months to 2024-09-30$400.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure458Cost of revenue, Q4 FY2024, three months to 2024-12-31$457.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure447Cost of revenue, Q1 FY2025, three months to 2025-03-31$447.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure468Cost of revenue, Q2 FY2025, three months to 2025-06-30$468.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure478Cost of revenue, Q3 FY2025, three months to 2025-09-30$477.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure467Cost of revenue, Q4 FY2025, three months to 2025-12-31$466.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure442Cost of revenue, Q1 FY2026, three months to 2026-03-31$441.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure478Cost of revenue, Q2 FY2026, three months to 2026-06-30$478.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Gross profit$m623Gross profit, Q3 FY2023, three months to 2023-09-30$623.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure657Gross profit, Q4 FY2023, three months to 2023-12-31$656.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure562Gross profit, Q1 FY2024, three months to 2024-03-31$561.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure627Gross profit, Q2 FY2024, three months to 2024-06-30$626.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure594Gross profit, Q3 FY2024, three months to 2024-09-30$593.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure656Gross profit, Q4 FY2024, three months to 2024-12-31$655.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure589Gross profit, Q1 FY2025, three months to 2025-03-31$589.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure689Gross profit, Q2 FY2025, three months to 2025-06-30$688.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure731Gross profit, Q3 FY2025, three months to 2025-09-30$731.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure793Gross profit, Q4 FY2025, three months to 2025-12-31$792.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure750Gross profit, Q1 FY2026, three months to 2026-03-31$750.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure830Gross profit, Q2 FY2026, three months to 2026-06-30$830.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Research and development$m131Research and development, Q3 FY2023, three months to 2023-09-30$131.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure136Research and development, Q4 FY2023, three months to 2023-12-31$136.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure142Research and development, Q1 FY2024, three months to 2024-03-31$141.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure136Research and development, Q2 FY2024, three months to 2024-06-30$136.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure135Research and development, Q3 FY2024, three months to 2024-09-30$135.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure140Research and development, Q4 FY2024, three months to 2024-12-31$139.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure145Research and development, Q1 FY2025, three months to 2025-03-31$145.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure148Research and development, Q2 FY2025, three months to 2025-06-30$148.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure158Research and development, Q3 FY2025, three months to 2025-09-30$157.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure148Research and development, Q4 FY2025, three months to 2025-12-31$148.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure145Research and development, Q1 FY2026, three months to 2026-03-31$145.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure153Research and development, Q2 FY2026, three months to 2026-06-30$153.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Selling, general and administrative$m286Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$286.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure304Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$303.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure319Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$319.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure333Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$332.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure306Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$306.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure327Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$327.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure310Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$310.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure328Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$328.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure331Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$331.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure322Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$321.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure350Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$349.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure359Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$358.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Operating income$m206Operating income, Q3 FY2023, three months to 2023-09-30$205.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure217Operating income, Q4 FY2023, three months to 2023-12-31$216.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure101Operating income, Q1 FY2024, three months to 2024-03-31$101.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure158Operating income, Q2 FY2024, three months to 2024-06-30$158.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure152Operating income, Q3 FY2024, three months to 2024-09-30$152.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure189Operating income, Q4 FY2024, three months to 2024-12-31$188.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure134Operating income, Q1 FY2025, three months to 2025-03-31$133.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure213Operating income, Q2 FY2025, three months to 2025-06-30$212.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure243Operating income, Q3 FY2025, three months to 2025-09-30$242.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure323Operating income, Q4 FY2025, three months to 2025-12-31$323.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure255Operating income, Q1 FY2026, three months to 2026-03-31$255.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure318Operating income, Q2 FY2026, three months to 2026-06-30$318.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Interest expense$m4.9Interest expense, Q3 FY2023, three months to 2023-09-30$4.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-10-26, accession 0001093557-23-000220.Report this figure4.9Interest expense, Q4 FY2023, three months to 2023-12-31$4.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-08, accession 0001093557-24-000021. Derived: 12-month figure less the 9-month figure.Report this figure4.6Interest expense, Q1 FY2024, three months to 2024-03-31$4.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-04-25, accession 0001093557-24-000079.Report this figure4.8Interest expense, Q2 FY2024, three months to 2024-06-30$4.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure4.7Interest expense, Q3 FY2024, three months to 2024-09-30$4.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure4.9Interest expense, Q4 FY2024, three months to 2024-12-31$4.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure4.7Interest expense, Q1 FY2025, three months to 2025-03-31$4.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure4.7Interest expense, Q2 FY2025, three months to 2025-06-30$4.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure4.7Interest expense, Q3 FY2025, three months to 2025-09-30$4.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure4.2Interest expense, Q4 FY2025, three months to 2025-12-31$4.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure3.1Interest expense, Q1 FY2026, three months to 2026-03-31$3.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure3.0Interest expense, Q2 FY2026, three months to 2026-06-30$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Income tax$m120Income tax, Q3 FY2023, three months to 2023-09-30$119.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure(10.1)Income tax, Q4 FY2023, three months to 2023-12-31−$10.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure(13.9)Income tax, Q1 FY2024, three months to 2024-03-31−$13.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure44.3Income tax, Q2 FY2024, three months to 2024-06-30$44.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure42.8Income tax, Q3 FY2024, three months to 2024-09-30$42.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure59.6Income tax, Q4 FY2024, three months to 2024-12-31$59.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure48.9Income tax, Q1 FY2025, three months to 2025-03-31$48.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure61.3Income tax, Q2 FY2025, three months to 2025-06-30$61.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure68.5Income tax, Q3 FY2025, three months to 2025-09-30$68.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure73.4Income tax, Q4 FY2025, three months to 2025-12-31$73.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure70.0Income tax, Q1 FY2026, three months to 2026-03-31$70.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure68.4Income tax, Q2 FY2026, three months to 2026-06-30$68.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Net income$m121Net income, Q3 FY2023, three months to 2023-09-30$120.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure256Net income, Q4 FY2023, three months to 2023-12-31$256.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure146Net income, Q1 FY2024, three months to 2024-03-31$146.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure144Net income, Q2 FY2024, three months to 2024-06-30$143.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure135Net income, Q3 FY2024, three months to 2024-09-30$134.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure152Net income, Q4 FY2024, three months to 2024-12-31$151.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure105Net income, Q1 FY2025, three months to 2025-03-31$105.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure180Net income, Q2 FY2025, three months to 2025-06-30$179.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure284Net income, Q3 FY2025, three months to 2025-09-30$283.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure267Net income, Q4 FY2025, three months to 2025-12-31$267.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure200Net income, Q1 FY2026, three months to 2026-03-31$199.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure249Net income, Q2 FY2026, three months to 2026-06-30$249.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Diluted EPS$ per share0.29Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figurenot reported0.36Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure0.35Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure0.34Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figurenot reported0.27Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure0.45Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure0.70Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figurenot reported0.51Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure0.64Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Basic EPS$ per share0.31Basic EPS, Q3 FY2023, three months to 2023-09-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figurenot reported0.38Basic EPS, Q1 FY2024, three months to 2024-03-31$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure0.36Basic EPS, Q2 FY2024, three months to 2024-06-30$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure0.34Basic EPS, Q3 FY2024, three months to 2024-09-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figurenot reported0.27Basic EPS, Q1 FY2025, three months to 2025-03-31$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure0.46Basic EPS, Q2 FY2025, three months to 2025-06-30$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure0.73Basic EPS, Q3 FY2025, three months to 2025-09-30$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figurenot reported0.52Basic EPS, Q1 FY2026, three months to 2026-03-31$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure0.65Basic EPS, Q2 FY2026, three months to 2026-06-30$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure

Balance sheet

Cash and equivalents$1.10bn, Q2 FY2026
Shareholders' equity$2.62bn, Q2 FY2026
Dexcom Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m644Cash and equivalents, Q3 FY2023, at 2023-09-30$643.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure566Cash and equivalents, FY2023, at 2023-12-31$566.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure851Cash and equivalents, Q1 FY2024, at 2024-03-31$851.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure939Cash and equivalents, Q2 FY2024, at 2024-06-30$939.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure621Cash and equivalents, Q3 FY2024, at 2024-09-30$621.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure606Cash and equivalents, FY2024, at 2024-12-31$606.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure905Cash and equivalents, Q1 FY2025, at 2025-03-31$904.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure1,159Cash and equivalents, Q2 FY2025, at 2025-06-30$1.16bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure1,836Cash and equivalents, Q3 FY2025, at 2025-09-30$1.84bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure918Cash and equivalents, FY2025, at 2025-12-31$917.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure1,118Cash and equivalents, Q1 FY2026, at 2026-03-31$1.12bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure1,105Cash and equivalents, Q2 FY2026, at 2026-06-30$1.10bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Current assets$m4,698Current assets, Q3 FY2023, at 2023-09-30$4.70bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-26, accession 0001093557-23-000220.Report this figure4,426Current assets, FY2023, at 2023-12-31$4.43bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure4,621Current assets, Q1 FY2024, at 2024-03-31$4.62bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-25, accession 0001093557-24-000079.Report this figure4,848Current assets, Q2 FY2024, at 2024-06-30$4.85bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-25, accession 0001093557-24-000144.Report this figure4,263Current assets, Q3 FY2024, at 2024-09-30$4.26bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure4,301Current assets, FY2024, at 2024-12-31$4.30bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure4,554Current assets, Q1 FY2025, at 2025-03-31$4.55bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure5,030Current assets, Q2 FY2025, at 2025-06-30$5.03bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure5,220Current assets, Q3 FY2025, at 2025-09-30$5.22bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure4,033Current assets, FY2025, at 2025-12-31$4.03bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure4,332Current assets, Q1 FY2026, at 2026-03-31$4.33bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure4,087Current assets, Q2 FY2026, at 2026-06-30$4.09bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Total assets$m6,596Total assets, Q3 FY2023, at 2023-09-30$6.60bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-26, accession 0001093557-23-000220.Report this figure6,265Total assets, FY2023, at 2023-12-31$6.26bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure6,482Total assets, Q1 FY2024, at 2024-03-31$6.48bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-25, accession 0001093557-24-000079.Report this figure6,799Total assets, Q2 FY2024, at 2024-06-30$6.80bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-25, accession 0001093557-24-000144.Report this figure6,354Total assets, Q3 FY2024, at 2024-09-30$6.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure6,485Total assets, FY2024, at 2024-12-31$6.48bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure6,752Total assets, Q1 FY2025, at 2025-03-31$6.75bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure7,327Total assets, Q2 FY2025, at 2025-06-30$7.33bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure7,500Total assets, Q3 FY2025, at 2025-09-30$7.50bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure6,340Total assets, FY2025, at 2025-12-31$6.34bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure6,633Total assets, Q1 FY2026, at 2026-03-31$6.63bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure6,455Total assets, Q2 FY2026, at 2026-06-30$6.46bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Current liabilities$m1,679Current liabilities, Q3 FY2023, at 2023-09-30$1.68bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-26, accession 0001093557-23-000220.Report this figure1,556Current liabilities, FY2023, at 2023-12-31$1.56bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure1,594Current liabilities, Q1 FY2024, at 2024-03-31$1.59bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-25, accession 0001093557-24-000079.Report this figure1,722Current liabilities, Q2 FY2024, at 2024-06-30$1.72bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-25, accession 0001093557-24-000144.Report this figure1,735Current liabilities, Q3 FY2024, at 2024-09-30$1.73bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure2,932Current liabilities, FY2024, at 2024-12-31$2.93bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure3,037Current liabilities, Q1 FY2025, at 2025-03-31$3.04bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure3,309Current liabilities, Q2 FY2025, at 2025-06-30$3.31bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure3,336Current liabilities, Q3 FY2025, at 2025-09-30$3.34bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure2,143Current liabilities, FY2025, at 2025-12-31$2.14bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure2,224Current liabilities, Q1 FY2026, at 2026-03-31$2.22bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure2,358Current liabilities, Q2 FY2026, at 2026-06-30$2.36bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Total liabilities$m4,328Total liabilities, Q3 FY2023, at 2023-09-30$4.33bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-10-26, accession 0001093557-23-000220.Report this figure4,196Total liabilities, FY2023, at 2023-12-31$4.20bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-18, accession 0001093557-25-000036.Report this figure4,235Total liabilities, Q1 FY2024, at 2024-03-31$4.24bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-25, accession 0001093557-24-000079.Report this figure4,365Total liabilities, Q2 FY2024, at 2024-06-30$4.36bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-25, accession 0001093557-24-000144.Report this figure4,375Total liabilities, Q3 FY2024, at 2024-09-30$4.37bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure4,382Total liabilities, FY2024, at 2024-12-31$4.38bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure4,485Total liabilities, Q1 FY2025, at 2025-03-31$4.49bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure4,754Total liabilities, Q2 FY2025, at 2025-06-30$4.75bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure4,774Total liabilities, Q3 FY2025, at 2025-09-30$4.77bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure3,594Total liabilities, FY2025, at 2025-12-31$3.59bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure3,676Total liabilities, Q1 FY2026, at 2026-03-31$3.68bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure3,834Total liabilities, Q2 FY2026, at 2026-06-30$3.83bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m2,268Shareholders' equity, Q3 FY2023, at 2023-09-30$2.27bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure2,069Shareholders' equity, FY2023, at 2023-12-31$2.07bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-12, accession 0001093557-26-000027.Report this figure2,247Shareholders' equity, Q1 FY2024, at 2024-03-31$2.25bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure2,434Shareholders' equity, Q2 FY2024, at 2024-06-30$2.43bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure1,979Shareholders' equity, Q3 FY2024, at 2024-09-30$1.98bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure2,103Shareholders' equity, FY2024, at 2024-12-31$2.10bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure2,267Shareholders' equity, Q1 FY2025, at 2025-03-31$2.27bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure2,573Shareholders' equity, Q2 FY2025, at 2025-06-30$2.57bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure2,726Shareholders' equity, Q3 FY2025, at 2025-09-30$2.73bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure2,746Shareholders' equity, FY2025, at 2025-12-31$2.75bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure2,957Shareholders' equity, Q1 FY2026, at 2026-03-31$2.96bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure2,621Shareholders' equity, Q2 FY2026, at 2026-06-30$2.62bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure

Cash flow

Operating cash flow$269.2m, Q2 FY2026
Capital expenditure$84.7m, Q2 FY2026
Share repurchases$312.8m, Q4 FY2025
Dexcom Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m269Operating cash flow, Q3 FY2023, three months to 2023-09-30$269.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-24, accession 0001093557-24-000180. Derived: 9-month figure less the 6-month figure.Report this figure134Operating cash flow, Q4 FY2023, three months to 2023-12-31$133.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure209Operating cash flow, Q1 FY2024, three months to 2024-03-31$209.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure279Operating cash flow, Q2 FY2024, three months to 2024-06-30$279.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001093557-25-000243. Derived: 6-month figure less the 3-month figure.Report this figure200Operating cash flow, Q3 FY2024, three months to 2024-09-30$199.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Report this figure301Operating cash flow, Q4 FY2024, three months to 2024-12-31$301.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure184Operating cash flow, Q1 FY2025, three months to 2025-03-31$183.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure303Operating cash flow, Q2 FY2025, three months to 2025-06-30$303.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Report this figure660Operating cash flow, Q3 FY2025, three months to 2025-09-30$659.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Report this figure294Operating cash flow, Q4 FY2025, three months to 2025-12-31$294.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure526Operating cash flow, Q1 FY2026, three months to 2026-03-31$525.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure269Operating cash flow, Q2 FY2026, three months to 2026-06-30$269.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m50.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$50.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-24, accession 0001093557-24-000180. Derived: 9-month figure less the 6-month figure.Report this figure52.5Capital expenditure, Q4 FY2023, three months to 2023-12-31$52.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure56.9Capital expenditure, Q1 FY2024, three months to 2024-03-31$56.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure66.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$66.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001093557-25-000243. Derived: 6-month figure less the 3-month figure.Report this figure111Capital expenditure, Q3 FY2024, three months to 2024-09-30$111.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Report this figure125Capital expenditure, Q4 FY2024, three months to 2024-12-31$124.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure87.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$87.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure94.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$94.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Report this figure80.5Capital expenditure, Q3 FY2025, three months to 2025-09-30$80.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Report this figure102Capital expenditure, Q4 FY2025, three months to 2025-12-31$101.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figure76.6Capital expenditure, Q1 FY2026, three months to 2026-03-31$76.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure84.7Capital expenditure, Q2 FY2026, three months to 2026-06-30$84.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001093557-26-000143. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-10-24, accession 0001093557-24-000180. Derived: 9-month figure less the 6-month figure.Report this figure500Share repurchases, Q4 FY2023, three months to 2023-12-31$500.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported750Share repurchases, Q3 FY2024, three months to 2024-09-30$750.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported187Share repurchases, Q3 FY2025, three months to 2025-09-30$187.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-30, accession 0001093557-25-000280. Derived: 9-month figure less the 6-month figure.Report this figure313Share repurchases, Q4 FY2025, three months to 2025-12-31$312.8m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-12, accession 0001093557-26-000027. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)390.10m, Q2 FY2026
Dexcom Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares426Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30425,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-10-26, accession 0001093557-23-000220.Report this figure419Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31418,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-25, accession 0001093557-24-000079.Report this figure432Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30431,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-25, accession 0001093557-24-000144.Report this figure427Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30426,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-24, accession 0001093557-24-000180.Report this figure417Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31416,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001093557-25-000113.Report this figure417Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30416,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0001093557-25-000243.Report this figure410Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30410,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure408Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31407,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure408Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30408,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure407Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30407,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001093557-25-000280.Report this figure394Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31393,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001093557-26-000073.Report this figure390Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30390,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure

Shares outstanding: 377.36mShares outstanding, period not labelled, at 2026-07-23377,360,765 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-30, accession 0001093557-26-000143.Report this figure at Jul 23, 2026, from the cover of the 10-Q filed Jul 30, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. Listed shows no prices and gives no investment advice.